news Naphthyridine-Azaquinolone reverses Huntington’s DNA repeats in mouse model 28 February 2020 | By Hannah Balfour (Drug Target Review) Researchers show Naphthyridine-Azaquinolone (NA) could be a possible future therapy able to slow the progression and improve the symptoms of Huntington’s disease.
news Mutations in non-coding regions of the cancer genome could drive tumour growth 20 January 2020 | By Hannah Balfour (Drug Target Review) Research into the role of non-coding DNA in cancer development and progression has identified 30 regions that may contribute to tumour growth, which could be therapeutic targets.
news Inhibiting protein slows glioblastoma tumour growth 11 July 2019 | By Victoria Rees (Drug Target Review) Researchers have discovered that inhibiting the ID1 protein slows the growth of glioblastoma tumours and reduces resistance to chemotherapy.